ADDUCE

What is the ADDUCE study about?
The Child and Adolescent Psychiatric Service of the Canton of Zurich is currently offering affected children and adolescents between the ages of 6 and 17 the opportunity to take part in an observational study on the drug treatment of ADHD. The study is investigating the long-term tolerability of methylphenidate (e.g. CONCERTA®, Equasym®, Equasym® Retard, Medikinet®, Medikinet® Retard, Ritalin® and Ritalin® LA). Several clinics throughout Germany and other European countries are also involved in conducting this study.